• Unpacking the Addition of New Variables to the Mantle Cell Lymphoma International Prognostic Index and MRD

  • Jan 31 2023
  • Length: 24 mins
  • Podcast

Unpacking the Addition of New Variables to the Mantle Cell Lymphoma International Prognostic Index and MRD

  • Summary

  • Drs Peter Martin and Eva Hoster discuss minimal residual disease, the Mantle Cell Lymphoma International Prognostic Index, and newer variable additions and their role in understanding recent findings.

    Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982889). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

    Resources

    Predictive Value of Minimal Residual Disease on Efficacy of Rituximab Maintenance in Mantle Cell Lymphoma: Results From the European MCL Elderly Trial https://ashpublications.org/blood/article/140/Supplement%201/1304/491631/Predictive-Value-of-Minimal-Residual-Disease-on

    Mantle Cell Lymphoma https://emedicine.medscape.com/article/203085-overview

    A New Prognostic Index (MIPI) for Patients With Advanced-Stage Mantle Cell Lymphoma https://pubmed.ncbi.nlm.nih.gov/17962512/

    German Lymphoma Alliance Scores https://www.german-lymphoma-alliance.de/Scores.html

    Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-term Follow-up of the Randomized European MCL Elderly Trial https://pubmed.ncbi.nlm.nih.gov/31804876/

    Rituximab-Lenalidomide (R2) Maintenance Is Superior to Rituximab Maintenance After First-line Immunochemotherapy in Mantle Cell Lymphoma: Results of the MCL R2 Elderly Clinical Trial https://ashpublications.org/blood/article/138/Supplement%201/379/478205/Rituximab-Lenalidomide-R2-Maintenance-Is-Superior

    ASCT After a Rituximab/Ibrutinib/Ara-c Containing iNduction in Generalized Mantle Cell Lymphoma https://clinicaltrials.gov/ct2/show/NCT02858258

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Unpacking the Addition of New Variables to the Mantle Cell Lymphoma International Prognostic Index and MRD

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.